Mednax Inc Stock Short Ratio
| MD Stock | USD 9.24 0.16 1.70% |
Mednax Inc fundamentals help investors to digest information that contributes to Mednax's financial success or failures. It also enables traders to predict the movement of Mednax Stock. The fundamental analysis module provides a way to measure Mednax's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mednax stock.
Mednax | Short Ratio |
Mednax Inc Company Short Ratio Analysis
Mednax's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Mednax Short Ratio | 5.43 X |
Most of Mednax's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mednax Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mednax Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Mednax is extremely important. It helps to project a fair market value of Mednax Stock properly, considering its historical fundamentals such as Short Ratio. Since Mednax's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mednax's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mednax's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Mednax Discontinued Operations
Discontinued Operations |
|
Based on the latest financial disclosure, Mednax Inc has a Short Ratio of 5.43 times. This is 39.23% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 35.75% lower than that of the firm.
Mednax Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednax's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mednax could also be used in its relative valuation, which is a method of valuing Mednax by comparing valuation metrics of similar companies.Mednax is currently under evaluation in short ratio category among related companies.
Mednax ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mednax's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mednax's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Mednax Institutional Holders
Institutional Holdings refers to the ownership stake in Mednax that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Mednax's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mednax's value.| Shares | Invenomic Capital Management, Lp | 2023-12-31 | 1.4 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.4 M | Boston Partners Global Investors, Inc | 2023-12-31 | 1.3 M | Amvescap Plc. | 2023-12-31 | 1 M | Aristotle Capital Boston, Llc | 2023-12-31 | 824.5 K | Northern Trust Corp | 2023-12-31 | 822.1 K | Bank Of New York Mellon Corp | 2023-12-31 | 741.4 K | Citadel Advisors Llc | 2023-09-30 | 740.1 K | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2023-12-31 | 694.2 K | Blackrock Inc | 2023-12-31 | 13.6 M | Vanguard Group Inc | 2023-12-31 | 10.4 M |
Mednax Fundamentals
| Return On Equity | -0.0694 | ||||
| Return On Asset | 0.0432 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 1.3 B | ||||
| Shares Outstanding | 84.03 M | ||||
| Shares Owned By Insiders | 1.37 % | ||||
| Shares Owned By Institutions | 98.63 % | ||||
| Number Of Shares Shorted | 4.12 M | ||||
| Price To Earning | 89.39 X | ||||
| Price To Book | 0.91 X | ||||
| Price To Sales | 0.39 X | ||||
| Revenue | 1.99 B | ||||
| Gross Profit | 467.03 M | ||||
| EBITDA | 196.08 M | ||||
| Net Income | (60.41 M) | ||||
| Cash And Equivalents | 9.82 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 701.65 M | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 1.39 X | ||||
| Book Value Per Share | 10.27 X | ||||
| Cash Flow From Operations | 137.32 M | ||||
| Short Ratio | 5.43 X | ||||
| Price To Earnings To Growth | 0.88 X | ||||
| Target Price | 9.07 | ||||
| Number Of Employees | 5.45 K | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 789.84 M | ||||
| Total Asset | 2.22 B | ||||
| Retained Earnings | (149.47 M) | ||||
| Working Capital | 94.51 M | ||||
| Current Asset | 527.77 M | ||||
| Current Liabilities | 428.77 M | ||||
| Net Asset | 2.22 B |
About Mednax Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mednax Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednax using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednax Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mednax Piotroski F Score and Mednax Altman Z Score analysis. Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Mednax Stock analysis
When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.31) | Revenue Per Share 24.265 | Quarterly Revenue Growth (0.03) | Return On Assets 0.0432 | Return On Equity (0.07) |
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.